Clinical Trials Browser

Phase 2 × Interventional × Squamous Cell Carcinoma of Anal Canal × Clear all

NCT03597295 2025-08-21

A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)

Phase 2 Completed

94 enrolled 18 charts 1 FDA

Gastrointestinal

Squamous Cell Carcinoma of Anal Canal

NCT01382745 2013-01-28

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Phase 2 Terminated

Gastrointestinal

Squamous Cell Carcinoma of Anal Canal